Stocks & ETFs

Latest News

Blogs & Articles

Stratagy Backtesting

Portfolio Analyser

Price Analyser

Compare Stocks

Stock & ETF Screener

Pricing

About The Company

CEO

Mr. Mike Q. Wang

Market Cap

156.07 Million USD

Sector

Healthcare

Website

https://www.americagreathealth.us

Description

America Great Health operates as a biotechnology company in the United States.

Read More

Overview

Value

1

Growth

36

Health

36

Management

50

Analyst Opinion

51

Total

35

All Scores Out Of 100

Best Features

  • Has a low level of debt
  • Low risk of bankruptcy
  • Low preportion of income is paid as dividend

Risk Factors

  • Overvalued on cashflow basis
  • Earnings have declined recently
  • Income is not covering expenditure and investment
  • Earnings are negative
  • There is a history of diluting shareholders
  • Does not hold enough liquid assets to cover short term liabilities
  • No margin of safety at their current market price
  • Poor earnings and cashflow growth

Market Peers

AAGH

Key Figures

PE Ratio (TTM)

N/A

Margin Of Safety (DCF)

-108.12%

Revenue Growth (5 Year Average)

38.14%

Ratings Consensus

Neutral

Share Buybacks

-1.04%

Dividend Yeild (TTM)

N/A

Valuation

Value Score

1

  • Estimated intrinsic-value of NaN undefined USD is lower than current price ( 7.40 undefined USD)
  • Free-cashflow-yeild of -0.96% is worse than the market average (4.7%)
  • Margin-of-safety of -108.12% is worse than the market average (17.95%)

Desired Margin Of Safety

0%

Tip: Set your desired Margin Of Safety

Free Cash Flow Type

Annual Cashflow Growth

0%

Discount Rate

0%

Buy Target: N/A

Current Price: 0 USD

Negative Cashflows: Cashflow can become negative due to operating losses, investing activities or financing activites. Negative cashflow makes it dificult to use a discounted free cashflow model to assess intrinsic value.

How Does This Work?

Show Advanced Options

This calculator helps investors estimate the Intrinsic Value of a company based on the current value of future cash flows. To use the tool, simply input a desired Margin Of Safety, which is an additional discount applied to the present value of the expected future cash flows. The tool calculates the present value using a discount rate that reflects the risk and time value of money, and provides an estimated target price for the company based on the selected margin of safety. The calculator defaults to using 5 Year Free Cash Flow Growth % and a discount rate based on the US 10-year treasury bond coupon rate. Use our performance analyser to get a feel the impact this has on longterm investment returns and discover a margin of safety you are comfortable with. This can be a useful tool for investors looking to make informed decisions about whether to buy or sell shares of a particular company.

Price/Earnings

N/Ax

Free Cashflow Yeild

-0.96%

PE/Earnings Growth

N/A

Price/Book

-40.43x

Growth

Growth Score

36

  • 5 Year Average Revenue growth of 38.14% is higher than the market average (10.97%)
  • Revenue growth has slowed this year
  • 5 Year Average Earnings growth of N/A is lower than the market average (14.48%)
  • Earnings growth has slowed this year
  • 5 Year Average Free Cashflow growth of -20.47% is lower than the market average (12.35%)
  • Free Cashflow growth has slowed this year

Revenue Growth

38.14%

Earnings Growth

N/A

Cashflow Growth

-20.47%

Health

Health Score

36

  • Low risk of bankruptcy
  • Has a low level of debt
  • Cashflow is negative
  • Assets do not cover liabilities
  • High financial leverage and base interest rate exposure
  • Requires debt for normal operation to be sustainable
  • Debt repayments significantly impact cashflow

Altman Z Score

20.00

Piostroski Score

4.00

Debt/Equity

N/Ax

Current Assets/Liabilities

0.07x

Free Cashflow/Total Debt

N/Ax

Debt/Capital

6.66x

Management

Management Score

50

  • Has issued new shares to finance growth when share price is high
  • Return-on-equity of 125.65% is higher than the market average (15%)
  • Return-on-capital-employed of -153.03% is lower than the market average (10%)
  • Has a history of diluting shareholders to finance activity

Average Buybacks/Dilution

-1.04%

Recent Buybacks/Dilution

0.00%

5 Year Price Volitility

117.09%

Return On Assets

-1443.06%

Return On Capital Employed

-153.03%

Return On Equity

125.65%

Return On Free Cashflow

1418.71%

Return On Investments

N/A

Analysts

Analyst Opinion

51

  • Ratings consensus is Neutral

SEC Filings

Find yearly (10-K), quaterly (10-Q) and disclosure (8-K) report here, on the Securities and Exchange Commission's EDGAR database. If reading through reports isn't your cup of tea, don't worry. We've made it easy for you by summarizing all the important bits.

Other Information

Company Name

America Great Health

Currency

USD

Beta

0.013951

Vol Avg

33020

Ceo

Mr. Mike Q. Wang

Cik

0001098009

Cusip

02365T101

Exchange

Other OTC

Full Time Employees

7

Industry

Biotechnology

Sector

Healthcare

Ipo Date

2012-09-25

Address

1609 West Valley Boulevard

City

Alhambra

State

CA

Country

US

Zip

91803

Phone

626-576-1299

All financial data provided by FMP

Noticed an error with something on our site?

We Use Cookies